Gene · 4939
Papers2,192
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,192
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deprenyl reduces inflammation during acute SIV infection. | iScience | 2022 | 35494221 | PubTator, text mining | PubMed |
| Inflammasome activation in infected macrophages drives COVID-19 pathology. | Nature | 2022 | 35483404 | PubTator, text mining | PubMed |
| Loss of METTL3 attenuates blastic plasmacytoid dendritic cell neoplasm response to PRMT5 inhibition via IFN signaling. | Blood Adv | 2022 | 35482445 | PubTator, text mining | PubMed |
| Functional network analysis of p85 and PI3K as potential gene targets and mechanism of oleanolic acid in overcoming breast cancer resistance to tamoxifen. | J Genet Eng Biotechnol | 2022 | 35482141 | PubTator, text mining | PubMed |
| Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2. | Emerg Microbes Infect | 2022 | 35476817 | PubTator, text mining | PubMed |
| The interferon-inducible GTPase MxB promotes capsid disassembly and genome release of herpesviruses. | Elife | 2022 | 35475759 | PubTator, text mining | PubMed |
| Placental dysfunction influences fetal monocyte subpopulation gene expression in preterm birth. | JCI Insight | 2022 | 35471950 | PubTator, text mining | PubMed |
| BNT162b2 vaccination enhances interferon-JAK-STAT-regulated antiviral programs in COVID-19 patients infected with the SARS-CoV-2 Beta variant. | Commun Med (Lond) | 2022 | 35465056 | PubTator, text mining | PubMed |
| Long-Read RNA Sequencing Identifies Polyadenylation Elongation and Differential Transcript Usage of Host Transcripts During SARS-CoV-2 In Vitro Infection. | Front Immunol | 2022 | 35464437 | PubTator, text mining | PubMed |
| Multi-Omics Integration Reveals Only Minor Long-Term Molecular and Functional Sequelae in Immune Cells of Individuals Recovered From COVID-19. | Front Immunol | 2022 | 35464396 | PubTator, text mining | PubMed |
| Treatment with Ad5-Porcine Interferon-α Attenuates Ebolavirus Disease in Pigs. | Pathogens | 2022 | 35456124 | PubTator, text mining | PubMed |
| Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm. | Life (Basel) | 2022 | 35454970 | PubTator, text mining | PubMed |
| Chrysin Ameliorates Influenza Virus Infection in the Upper Airways by Repressing Virus-Induced Cell Cycle Arrest and Mitochondria-Dependent Apoptosis. | Front Immunol | 2022 | 35432374 | PubTator, text mining | PubMed |
| Recurrent transcriptional responses in AML and MDS patients treated with decitabine. | Exp Hematol | 2022 | 35429619 | PubTator, text mining | PubMed |
| Combination of Enrichment Using Gene Ontology and Transcriptomic Analysis Revealed Contribution of Interferon Signaling to Severity of COVID-19. | Interdiscip Perspect Infect Dis | 2022 | 35422859 | PubTator, text mining | PubMed |
| Inducible CRISPR activation screen for interferon-stimulated genes identifies OAS1 as a SARS-CoV-2 restriction factor. | PLoS Pathog | 2022 | 35421191 | PubTator, text mining | PubMed |
| RNA sensor MDA5 suppresses LINE-1 retrotransposition by regulating the promoter activity of LINE-1 5'-UTR. | Mob DNA | 2022 | 35414110 | PubTator, text mining | PubMed |
| The Antiviral Effect of Isatis Root Polysaccharide against NADC30-like PRRSV by Transcriptome and Proteome Analysis. | Int J Mol Sci | 2022 | 35409050 | PubTator, text mining | PubMed |
| Differential Transcriptomics Analysis of IPEC-J2 Cells Single or Coinfected With Porcine Epidemic Diarrhea Virus and Transmissible Gastroenteritis Virus. | Front Immunol | 2022 | 35401515 | PubTator, text mining | PubMed |
| An Evolutionary Insight Into the Heterogeneous Severity Pattern of the SARS-CoV-2 Infection. | Front Genet | 2022 | 35391792 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4939/papers?page=32